Page last updated: 2024-08-17

cycloheximide and Neuroectodermal Tumors, Primitive

cycloheximide has been researched along with Neuroectodermal Tumors, Primitive in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brodeur, GM; Eggert, A; Grotzer, MA; Ikegaki, N; Janss, AJ; Marwaha, S; Phillips, PC; Wiewrodt, BR; Zuzak, TJ1

Other Studies

1 other study(ies) available for cycloheximide and Neuroectodermal Tumors, Primitive

ArticleYear
Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression.
    Oncogene, 2000, Sep-21, Volume: 19, Issue:40

    Topics: Adult; Antimetabolites, Antineoplastic; Apoptosis; Apoptosis Regulatory Proteins; Azacitidine; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 8; Caspase 9; Caspases; Child; Cycloheximide; Decitabine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Resistance; Enzyme Induction; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Intracellular Signaling Peptides and Proteins; Jurkat Cells; Membrane Glycoproteins; Neoplasm Proteins; Neuroectodermal Tumors, Primitive; Protein Synthesis Inhibitors; Receptors, Tumor Necrosis Factor; Recombinant Proteins; RNA, Messenger; RNA, Neoplasm; TNF-Related Apoptosis-Inducing Ligand; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

2000